A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
Radical cure of Plasmodium vivax malaria must include elimination of quiescent ‘hypnozoite’ forms in the liver; however, the only FDA-approved treatments are contraindicated in many vulnerable populations. To identify new drugs and drug targets for hypnozoites, we screened the Repurposing, Focused R...
Gespeichert in:
Veröffentlicht in: | PLoS pathogens 2024-05, Vol.16 (2) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | |
container_title | PLoS pathogens |
container_volume | 16 |
creator | Maher, S. Bakowski, M. Vantaux, A. Flannery, E. Andolina, C. Gupta, M. Antonova-Koch, Y. Argomaniz, M. Cabrera-Mora, M. Campo, B. Chao, A. Chatterjee, A. Cheng, W. Chuenchob, E. Cooper, C. Cottier, K. Galinski, M. Harupa-Chung, A. Ji, H. Joseph, S. Lenz, T. Lonardi, S. Matheson, J. Mikolajczak, S. Moeller, T. Orban, A. Padín-Irizarry, V. Pan, K. Péneau, J. Prudhomme, J. Roesch, Camille Ruberto, A. Sabnis, S. Saney, C. Sattabongkot, J. Sereshki, S. Suriyakan, S. Ubalee, R. Wang, Y. Wasisakun, P. Yin, J. Popovici, Jean Mcnamara, C. Joyner, C. Nosten, F. Witkowski, B. Le Roch, K. Kyle, D. |
description | Radical cure of Plasmodium vivax malaria must include elimination of quiescent ‘hypnozoite’ forms in the liver; however, the only FDA-approved treatments are contraindicated in many vulnerable populations. To identify new drugs and drug targets for hypnozoites, we screened the Repurposing, Focused Rescue, and Accelerated Medchem (ReFRAME) library and a collection of epigenetic inhibitors against P. vivax liver stages. From both libraries, we identified inhibitors targeting epigenetics pathways as selectively active against P. vivax and P. cynomolgi hypnozoites. These include DNA methyltransferase (DNMT) inhibitors as well as several inhibitors targeting histone post-translational modifications. Immunofluorescence staining of Plasmodium liver forms showed strong nuclear 5-methylcystosine signal, indicating liver stage parasite DNA is methylated. Using bisulfite sequencing, we mapped genomic DNA methylation in sporozoites, revealing DNA methylation signals in most coding genes. We also demonstrated that methylation level in proximal promoter regions as well as in the first exon of the genes may affect, at least partially, gene expression in P. vivax . The importance of selective inhibitors targeting epigenetic features on hypnozoites was validated using MMV019721, an acetyl-CoA synthetase inhibitor that affects histone acetylation and was previously reported as active against P. falciparum blood stages. In summary, our data indicate that several epigenetic mechanisms are likely modulating hypnozoite formation or persistence and provide an avenue for the discovery and development of improved radical cure antimalarials. |
doi_str_mv | 10.7554/eLife.98221.1 |
format | Article |
fullrecord | <record><control><sourceid>hal</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04671691v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_04671691v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-h731-a5a3e84b4e246ec8b038bc431c53228791e8fcb9b7b424d456649b1612c20c253</originalsourceid><addsrcrecordid>eNo9jDtPwzAYAC0EEqUwsntlSMnnZzJG5VGkSFSoe2S7XxOjNLHiNFB-PUUgpjvdcITcQrrQUop7LP0OF3nGGCzgjMxASp5orsX5vyt1Sa5ifE9TARzUjNiCPgyHmr5hOAyhj76raRHC0BvXnOKEpo10Y4YaR2NbpI_B19jh6B1dm7H5MMdIfUfXrYn7fusPezr5yXzS1TF0_VfvR4zX5GJ3uuDNH-dk8_S4Wa6S8vX5ZVmUSaM5JEYajpmwAplQ6DKb8sw6wcFJzlimc8Bs52xutRVMbIVUSuQWFDDHUsckn5O7321j2ioMfm-GY9UbX62KsvppqVAaVA4T8G9l-lkv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><creator>Maher, S. ; Bakowski, M. ; Vantaux, A. ; Flannery, E. ; Andolina, C. ; Gupta, M. ; Antonova-Koch, Y. ; Argomaniz, M. ; Cabrera-Mora, M. ; Campo, B. ; Chao, A. ; Chatterjee, A. ; Cheng, W. ; Chuenchob, E. ; Cooper, C. ; Cottier, K. ; Galinski, M. ; Harupa-Chung, A. ; Ji, H. ; Joseph, S. ; Lenz, T. ; Lonardi, S. ; Matheson, J. ; Mikolajczak, S. ; Moeller, T. ; Orban, A. ; Padín-Irizarry, V. ; Pan, K. ; Péneau, J. ; Prudhomme, J. ; Roesch, Camille ; Ruberto, A. ; Sabnis, S. ; Saney, C. ; Sattabongkot, J. ; Sereshki, S. ; Suriyakan, S. ; Ubalee, R. ; Wang, Y. ; Wasisakun, P. ; Yin, J. ; Popovici, Jean ; Mcnamara, C. ; Joyner, C. ; Nosten, F. ; Witkowski, B. ; Le Roch, K. ; Kyle, D.</creator><creatorcontrib>Maher, S. ; Bakowski, M. ; Vantaux, A. ; Flannery, E. ; Andolina, C. ; Gupta, M. ; Antonova-Koch, Y. ; Argomaniz, M. ; Cabrera-Mora, M. ; Campo, B. ; Chao, A. ; Chatterjee, A. ; Cheng, W. ; Chuenchob, E. ; Cooper, C. ; Cottier, K. ; Galinski, M. ; Harupa-Chung, A. ; Ji, H. ; Joseph, S. ; Lenz, T. ; Lonardi, S. ; Matheson, J. ; Mikolajczak, S. ; Moeller, T. ; Orban, A. ; Padín-Irizarry, V. ; Pan, K. ; Péneau, J. ; Prudhomme, J. ; Roesch, Camille ; Ruberto, A. ; Sabnis, S. ; Saney, C. ; Sattabongkot, J. ; Sereshki, S. ; Suriyakan, S. ; Ubalee, R. ; Wang, Y. ; Wasisakun, P. ; Yin, J. ; Popovici, Jean ; Mcnamara, C. ; Joyner, C. ; Nosten, F. ; Witkowski, B. ; Le Roch, K. ; Kyle, D.</creatorcontrib><description>Radical cure of Plasmodium vivax malaria must include elimination of quiescent ‘hypnozoite’ forms in the liver; however, the only FDA-approved treatments are contraindicated in many vulnerable populations. To identify new drugs and drug targets for hypnozoites, we screened the Repurposing, Focused Rescue, and Accelerated Medchem (ReFRAME) library and a collection of epigenetic inhibitors against P. vivax liver stages. From both libraries, we identified inhibitors targeting epigenetics pathways as selectively active against P. vivax and P. cynomolgi hypnozoites. These include DNA methyltransferase (DNMT) inhibitors as well as several inhibitors targeting histone post-translational modifications. Immunofluorescence staining of Plasmodium liver forms showed strong nuclear 5-methylcystosine signal, indicating liver stage parasite DNA is methylated. Using bisulfite sequencing, we mapped genomic DNA methylation in sporozoites, revealing DNA methylation signals in most coding genes. We also demonstrated that methylation level in proximal promoter regions as well as in the first exon of the genes may affect, at least partially, gene expression in P. vivax . The importance of selective inhibitors targeting epigenetic features on hypnozoites was validated using MMV019721, an acetyl-CoA synthetase inhibitor that affects histone acetylation and was previously reported as active against P. falciparum blood stages. In summary, our data indicate that several epigenetic mechanisms are likely modulating hypnozoite formation or persistence and provide an avenue for the discovery and development of improved radical cure antimalarials.</description><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.7554/eLife.98221.1</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Life Sciences</subject><ispartof>PLoS pathogens, 2024-05, Vol.16 (2)</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0665-7954 ; 0000-0002-9994-0291 ; 0000-0002-3938-4588 ; 0000-0002-8599-6382 ; 0000-0002-0238-965X ; 0000-0003-1367-2829 ; 0000-0002-5754-3407 ; 0000-0003-2862-0407 ; 0000-0002-2810-4501 ; 0000-0002-7945-961X ; 0000-0002-2696-7274 ; 0000-0002-7951-0745 ; 0000-0002-3337-6528 ; 0000-0002-0222-4679 ; 0000-0003-1996-9703 ; 0000-0001-5171-7982 ; 0000-0002-5119-0655 ; 0000-0002-9560-5656 ; 0000-0003-3387-644X ; 0000-0002-4862-9292 ; 0000-0002-3135-1175</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,864,885,27924,27925</link.rule.ids><backlink>$$Uhttps://hal.science/hal-04671691$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Maher, S.</creatorcontrib><creatorcontrib>Bakowski, M.</creatorcontrib><creatorcontrib>Vantaux, A.</creatorcontrib><creatorcontrib>Flannery, E.</creatorcontrib><creatorcontrib>Andolina, C.</creatorcontrib><creatorcontrib>Gupta, M.</creatorcontrib><creatorcontrib>Antonova-Koch, Y.</creatorcontrib><creatorcontrib>Argomaniz, M.</creatorcontrib><creatorcontrib>Cabrera-Mora, M.</creatorcontrib><creatorcontrib>Campo, B.</creatorcontrib><creatorcontrib>Chao, A.</creatorcontrib><creatorcontrib>Chatterjee, A.</creatorcontrib><creatorcontrib>Cheng, W.</creatorcontrib><creatorcontrib>Chuenchob, E.</creatorcontrib><creatorcontrib>Cooper, C.</creatorcontrib><creatorcontrib>Cottier, K.</creatorcontrib><creatorcontrib>Galinski, M.</creatorcontrib><creatorcontrib>Harupa-Chung, A.</creatorcontrib><creatorcontrib>Ji, H.</creatorcontrib><creatorcontrib>Joseph, S.</creatorcontrib><creatorcontrib>Lenz, T.</creatorcontrib><creatorcontrib>Lonardi, S.</creatorcontrib><creatorcontrib>Matheson, J.</creatorcontrib><creatorcontrib>Mikolajczak, S.</creatorcontrib><creatorcontrib>Moeller, T.</creatorcontrib><creatorcontrib>Orban, A.</creatorcontrib><creatorcontrib>Padín-Irizarry, V.</creatorcontrib><creatorcontrib>Pan, K.</creatorcontrib><creatorcontrib>Péneau, J.</creatorcontrib><creatorcontrib>Prudhomme, J.</creatorcontrib><creatorcontrib>Roesch, Camille</creatorcontrib><creatorcontrib>Ruberto, A.</creatorcontrib><creatorcontrib>Sabnis, S.</creatorcontrib><creatorcontrib>Saney, C.</creatorcontrib><creatorcontrib>Sattabongkot, J.</creatorcontrib><creatorcontrib>Sereshki, S.</creatorcontrib><creatorcontrib>Suriyakan, S.</creatorcontrib><creatorcontrib>Ubalee, R.</creatorcontrib><creatorcontrib>Wang, Y.</creatorcontrib><creatorcontrib>Wasisakun, P.</creatorcontrib><creatorcontrib>Yin, J.</creatorcontrib><creatorcontrib>Popovici, Jean</creatorcontrib><creatorcontrib>Mcnamara, C.</creatorcontrib><creatorcontrib>Joyner, C.</creatorcontrib><creatorcontrib>Nosten, F.</creatorcontrib><creatorcontrib>Witkowski, B.</creatorcontrib><creatorcontrib>Le Roch, K.</creatorcontrib><creatorcontrib>Kyle, D.</creatorcontrib><title>A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites</title><title>PLoS pathogens</title><description>Radical cure of Plasmodium vivax malaria must include elimination of quiescent ‘hypnozoite’ forms in the liver; however, the only FDA-approved treatments are contraindicated in many vulnerable populations. To identify new drugs and drug targets for hypnozoites, we screened the Repurposing, Focused Rescue, and Accelerated Medchem (ReFRAME) library and a collection of epigenetic inhibitors against P. vivax liver stages. From both libraries, we identified inhibitors targeting epigenetics pathways as selectively active against P. vivax and P. cynomolgi hypnozoites. These include DNA methyltransferase (DNMT) inhibitors as well as several inhibitors targeting histone post-translational modifications. Immunofluorescence staining of Plasmodium liver forms showed strong nuclear 5-methylcystosine signal, indicating liver stage parasite DNA is methylated. Using bisulfite sequencing, we mapped genomic DNA methylation in sporozoites, revealing DNA methylation signals in most coding genes. We also demonstrated that methylation level in proximal promoter regions as well as in the first exon of the genes may affect, at least partially, gene expression in P. vivax . The importance of selective inhibitors targeting epigenetic features on hypnozoites was validated using MMV019721, an acetyl-CoA synthetase inhibitor that affects histone acetylation and was previously reported as active against P. falciparum blood stages. In summary, our data indicate that several epigenetic mechanisms are likely modulating hypnozoite formation or persistence and provide an avenue for the discovery and development of improved radical cure antimalarials.</description><subject>Life Sciences</subject><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9jDtPwzAYAC0EEqUwsntlSMnnZzJG5VGkSFSoe2S7XxOjNLHiNFB-PUUgpjvdcITcQrrQUop7LP0OF3nGGCzgjMxASp5orsX5vyt1Sa5ifE9TARzUjNiCPgyHmr5hOAyhj76raRHC0BvXnOKEpo10Y4YaR2NbpI_B19jh6B1dm7H5MMdIfUfXrYn7fusPezr5yXzS1TF0_VfvR4zX5GJ3uuDNH-dk8_S4Wa6S8vX5ZVmUSaM5JEYajpmwAplQ6DKb8sw6wcFJzlimc8Bs52xutRVMbIVUSuQWFDDHUsckn5O7321j2ioMfm-GY9UbX62KsvppqVAaVA4T8G9l-lkv</recordid><startdate>20240524</startdate><enddate>20240524</enddate><creator>Maher, S.</creator><creator>Bakowski, M.</creator><creator>Vantaux, A.</creator><creator>Flannery, E.</creator><creator>Andolina, C.</creator><creator>Gupta, M.</creator><creator>Antonova-Koch, Y.</creator><creator>Argomaniz, M.</creator><creator>Cabrera-Mora, M.</creator><creator>Campo, B.</creator><creator>Chao, A.</creator><creator>Chatterjee, A.</creator><creator>Cheng, W.</creator><creator>Chuenchob, E.</creator><creator>Cooper, C.</creator><creator>Cottier, K.</creator><creator>Galinski, M.</creator><creator>Harupa-Chung, A.</creator><creator>Ji, H.</creator><creator>Joseph, S.</creator><creator>Lenz, T.</creator><creator>Lonardi, S.</creator><creator>Matheson, J.</creator><creator>Mikolajczak, S.</creator><creator>Moeller, T.</creator><creator>Orban, A.</creator><creator>Padín-Irizarry, V.</creator><creator>Pan, K.</creator><creator>Péneau, J.</creator><creator>Prudhomme, J.</creator><creator>Roesch, Camille</creator><creator>Ruberto, A.</creator><creator>Sabnis, S.</creator><creator>Saney, C.</creator><creator>Sattabongkot, J.</creator><creator>Sereshki, S.</creator><creator>Suriyakan, S.</creator><creator>Ubalee, R.</creator><creator>Wang, Y.</creator><creator>Wasisakun, P.</creator><creator>Yin, J.</creator><creator>Popovici, Jean</creator><creator>Mcnamara, C.</creator><creator>Joyner, C.</creator><creator>Nosten, F.</creator><creator>Witkowski, B.</creator><creator>Le Roch, K.</creator><creator>Kyle, D.</creator><general>Public Library of Science</general><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-0665-7954</orcidid><orcidid>https://orcid.org/0000-0002-9994-0291</orcidid><orcidid>https://orcid.org/0000-0002-3938-4588</orcidid><orcidid>https://orcid.org/0000-0002-8599-6382</orcidid><orcidid>https://orcid.org/0000-0002-0238-965X</orcidid><orcidid>https://orcid.org/0000-0003-1367-2829</orcidid><orcidid>https://orcid.org/0000-0002-5754-3407</orcidid><orcidid>https://orcid.org/0000-0003-2862-0407</orcidid><orcidid>https://orcid.org/0000-0002-2810-4501</orcidid><orcidid>https://orcid.org/0000-0002-7945-961X</orcidid><orcidid>https://orcid.org/0000-0002-2696-7274</orcidid><orcidid>https://orcid.org/0000-0002-7951-0745</orcidid><orcidid>https://orcid.org/0000-0002-3337-6528</orcidid><orcidid>https://orcid.org/0000-0002-0222-4679</orcidid><orcidid>https://orcid.org/0000-0003-1996-9703</orcidid><orcidid>https://orcid.org/0000-0001-5171-7982</orcidid><orcidid>https://orcid.org/0000-0002-5119-0655</orcidid><orcidid>https://orcid.org/0000-0002-9560-5656</orcidid><orcidid>https://orcid.org/0000-0003-3387-644X</orcidid><orcidid>https://orcid.org/0000-0002-4862-9292</orcidid><orcidid>https://orcid.org/0000-0002-3135-1175</orcidid></search><sort><creationdate>20240524</creationdate><title>A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites</title><author>Maher, S. ; Bakowski, M. ; Vantaux, A. ; Flannery, E. ; Andolina, C. ; Gupta, M. ; Antonova-Koch, Y. ; Argomaniz, M. ; Cabrera-Mora, M. ; Campo, B. ; Chao, A. ; Chatterjee, A. ; Cheng, W. ; Chuenchob, E. ; Cooper, C. ; Cottier, K. ; Galinski, M. ; Harupa-Chung, A. ; Ji, H. ; Joseph, S. ; Lenz, T. ; Lonardi, S. ; Matheson, J. ; Mikolajczak, S. ; Moeller, T. ; Orban, A. ; Padín-Irizarry, V. ; Pan, K. ; Péneau, J. ; Prudhomme, J. ; Roesch, Camille ; Ruberto, A. ; Sabnis, S. ; Saney, C. ; Sattabongkot, J. ; Sereshki, S. ; Suriyakan, S. ; Ubalee, R. ; Wang, Y. ; Wasisakun, P. ; Yin, J. ; Popovici, Jean ; Mcnamara, C. ; Joyner, C. ; Nosten, F. ; Witkowski, B. ; Le Roch, K. ; Kyle, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h731-a5a3e84b4e246ec8b038bc431c53228791e8fcb9b7b424d456649b1612c20c253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maher, S.</creatorcontrib><creatorcontrib>Bakowski, M.</creatorcontrib><creatorcontrib>Vantaux, A.</creatorcontrib><creatorcontrib>Flannery, E.</creatorcontrib><creatorcontrib>Andolina, C.</creatorcontrib><creatorcontrib>Gupta, M.</creatorcontrib><creatorcontrib>Antonova-Koch, Y.</creatorcontrib><creatorcontrib>Argomaniz, M.</creatorcontrib><creatorcontrib>Cabrera-Mora, M.</creatorcontrib><creatorcontrib>Campo, B.</creatorcontrib><creatorcontrib>Chao, A.</creatorcontrib><creatorcontrib>Chatterjee, A.</creatorcontrib><creatorcontrib>Cheng, W.</creatorcontrib><creatorcontrib>Chuenchob, E.</creatorcontrib><creatorcontrib>Cooper, C.</creatorcontrib><creatorcontrib>Cottier, K.</creatorcontrib><creatorcontrib>Galinski, M.</creatorcontrib><creatorcontrib>Harupa-Chung, A.</creatorcontrib><creatorcontrib>Ji, H.</creatorcontrib><creatorcontrib>Joseph, S.</creatorcontrib><creatorcontrib>Lenz, T.</creatorcontrib><creatorcontrib>Lonardi, S.</creatorcontrib><creatorcontrib>Matheson, J.</creatorcontrib><creatorcontrib>Mikolajczak, S.</creatorcontrib><creatorcontrib>Moeller, T.</creatorcontrib><creatorcontrib>Orban, A.</creatorcontrib><creatorcontrib>Padín-Irizarry, V.</creatorcontrib><creatorcontrib>Pan, K.</creatorcontrib><creatorcontrib>Péneau, J.</creatorcontrib><creatorcontrib>Prudhomme, J.</creatorcontrib><creatorcontrib>Roesch, Camille</creatorcontrib><creatorcontrib>Ruberto, A.</creatorcontrib><creatorcontrib>Sabnis, S.</creatorcontrib><creatorcontrib>Saney, C.</creatorcontrib><creatorcontrib>Sattabongkot, J.</creatorcontrib><creatorcontrib>Sereshki, S.</creatorcontrib><creatorcontrib>Suriyakan, S.</creatorcontrib><creatorcontrib>Ubalee, R.</creatorcontrib><creatorcontrib>Wang, Y.</creatorcontrib><creatorcontrib>Wasisakun, P.</creatorcontrib><creatorcontrib>Yin, J.</creatorcontrib><creatorcontrib>Popovici, Jean</creatorcontrib><creatorcontrib>Mcnamara, C.</creatorcontrib><creatorcontrib>Joyner, C.</creatorcontrib><creatorcontrib>Nosten, F.</creatorcontrib><creatorcontrib>Witkowski, B.</creatorcontrib><creatorcontrib>Le Roch, K.</creatorcontrib><creatorcontrib>Kyle, D.</creatorcontrib><collection>Hyper Article en Ligne (HAL)</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maher, S.</au><au>Bakowski, M.</au><au>Vantaux, A.</au><au>Flannery, E.</au><au>Andolina, C.</au><au>Gupta, M.</au><au>Antonova-Koch, Y.</au><au>Argomaniz, M.</au><au>Cabrera-Mora, M.</au><au>Campo, B.</au><au>Chao, A.</au><au>Chatterjee, A.</au><au>Cheng, W.</au><au>Chuenchob, E.</au><au>Cooper, C.</au><au>Cottier, K.</au><au>Galinski, M.</au><au>Harupa-Chung, A.</au><au>Ji, H.</au><au>Joseph, S.</au><au>Lenz, T.</au><au>Lonardi, S.</au><au>Matheson, J.</au><au>Mikolajczak, S.</au><au>Moeller, T.</au><au>Orban, A.</au><au>Padín-Irizarry, V.</au><au>Pan, K.</au><au>Péneau, J.</au><au>Prudhomme, J.</au><au>Roesch, Camille</au><au>Ruberto, A.</au><au>Sabnis, S.</au><au>Saney, C.</au><au>Sattabongkot, J.</au><au>Sereshki, S.</au><au>Suriyakan, S.</au><au>Ubalee, R.</au><au>Wang, Y.</au><au>Wasisakun, P.</au><au>Yin, J.</au><au>Popovici, Jean</au><au>Mcnamara, C.</au><au>Joyner, C.</au><au>Nosten, F.</au><au>Witkowski, B.</au><au>Le Roch, K.</au><au>Kyle, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites</atitle><jtitle>PLoS pathogens</jtitle><date>2024-05-24</date><risdate>2024</risdate><volume>16</volume><issue>2</issue><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Radical cure of Plasmodium vivax malaria must include elimination of quiescent ‘hypnozoite’ forms in the liver; however, the only FDA-approved treatments are contraindicated in many vulnerable populations. To identify new drugs and drug targets for hypnozoites, we screened the Repurposing, Focused Rescue, and Accelerated Medchem (ReFRAME) library and a collection of epigenetic inhibitors against P. vivax liver stages. From both libraries, we identified inhibitors targeting epigenetics pathways as selectively active against P. vivax and P. cynomolgi hypnozoites. These include DNA methyltransferase (DNMT) inhibitors as well as several inhibitors targeting histone post-translational modifications. Immunofluorescence staining of Plasmodium liver forms showed strong nuclear 5-methylcystosine signal, indicating liver stage parasite DNA is methylated. Using bisulfite sequencing, we mapped genomic DNA methylation in sporozoites, revealing DNA methylation signals in most coding genes. We also demonstrated that methylation level in proximal promoter regions as well as in the first exon of the genes may affect, at least partially, gene expression in P. vivax . The importance of selective inhibitors targeting epigenetic features on hypnozoites was validated using MMV019721, an acetyl-CoA synthetase inhibitor that affects histone acetylation and was previously reported as active against P. falciparum blood stages. In summary, our data indicate that several epigenetic mechanisms are likely modulating hypnozoite formation or persistence and provide an avenue for the discovery and development of improved radical cure antimalarials.</abstract><pub>Public Library of Science</pub><doi>10.7554/eLife.98221.1</doi><orcidid>https://orcid.org/0000-0003-0665-7954</orcidid><orcidid>https://orcid.org/0000-0002-9994-0291</orcidid><orcidid>https://orcid.org/0000-0002-3938-4588</orcidid><orcidid>https://orcid.org/0000-0002-8599-6382</orcidid><orcidid>https://orcid.org/0000-0002-0238-965X</orcidid><orcidid>https://orcid.org/0000-0003-1367-2829</orcidid><orcidid>https://orcid.org/0000-0002-5754-3407</orcidid><orcidid>https://orcid.org/0000-0003-2862-0407</orcidid><orcidid>https://orcid.org/0000-0002-2810-4501</orcidid><orcidid>https://orcid.org/0000-0002-7945-961X</orcidid><orcidid>https://orcid.org/0000-0002-2696-7274</orcidid><orcidid>https://orcid.org/0000-0002-7951-0745</orcidid><orcidid>https://orcid.org/0000-0002-3337-6528</orcidid><orcidid>https://orcid.org/0000-0002-0222-4679</orcidid><orcidid>https://orcid.org/0000-0003-1996-9703</orcidid><orcidid>https://orcid.org/0000-0001-5171-7982</orcidid><orcidid>https://orcid.org/0000-0002-5119-0655</orcidid><orcidid>https://orcid.org/0000-0002-9560-5656</orcidid><orcidid>https://orcid.org/0000-0003-3387-644X</orcidid><orcidid>https://orcid.org/0000-0002-4862-9292</orcidid><orcidid>https://orcid.org/0000-0002-3135-1175</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-7366 |
ispartof | PLoS pathogens, 2024-05, Vol.16 (2) |
issn | 1553-7366 1553-7374 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_04671691v1 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Public Library of Science (PLoS); PubMed Central |
subjects | Life Sciences |
title | A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A57%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Drug%20Repurposing%20Approach%20Reveals%20Targetable%20Epigenetic%20Pathways%20in%20Plasmodium%20vivax%20Hypnozoites&rft.jtitle=PLoS%20pathogens&rft.au=Maher,%20S.&rft.date=2024-05-24&rft.volume=16&rft.issue=2&rft.issn=1553-7366&rft.eissn=1553-7374&rft_id=info:doi/10.7554/eLife.98221.1&rft_dat=%3Chal%3Eoai_HAL_hal_04671691v1%3C/hal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |